Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Minden

Showing results (11-20 of 308) with videos related to

Pageof 31
Sort By:
Leukemia Research|July 16, 2003
Prognostic significance of trisomy 4 as the sole cytogenetic abnormality in acute myeloid leukemiaVikas Gupta, Mark D Minden, Qi-Long Yi, et al.
Nutrition and Cancer|January 31, 2025
Dietary Modulation of Fatty Acid Oxidation Imparts Stem Cell Protection in Bone MarrowNawaz Ahmed, Sarah Walker, Alessia Roma, et al.
Molecular & Cellular Oncology|October 7, 2021
Novel subtypes of <i>NPM1</i>-mutated AML with distinct outcomeArvind Singh Mer, Mark D Minden, Benjamin Haibe-Kains, et al.
International Journal of Molecular Sciences|June 27, 2024
Pseudolaric Acid B Targets CD147 to Selectively Kill Acute Myeloid Leukemia CellsSheng Zou, Ekaterina Parfenova, Nikolina Vrdoljak, et al.
Leukemia|December 14, 2019
NPM1c impedes CTCF functions through cytoplasmic mislocalization in acute myeloid leukemiaAtom J Wang, Youqi Han, Nanyang Jia, et al.
Current Treatment Options in Oncology|April 30, 2003
Bcl-2 and apoptosis in chronic lymphocytic leukemiaAaron D Schimmer, Irene Munk-Pedersen, Mark D Minden, et al.
Breast Cancer Research : BCR|July 20, 2007
The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cellsYouqi Han, Serban San-Marina, Lin Yang, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 26, 2018
Targeting chemotherapy-resistant leukemia by combining DNT cellular therapy with conventional chemotherapyBranson Chen, Jong Bok Lee, Hyeonjeong Kang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 16, 2008
Drug-resistant AML cells and primary AML specimens are killed by 111In-anti-CD33 monoclonal antibodies modified with nuclear localizing peptide sequencesVeerle Kersemans, Bart Cornelissen, Mark D Minden, et al.
Clinical Laboratory International|January 5, 2016
Insights into acute myeloid leukemia via single cell network profilingSteven M Kornblau, Mark D Minden, Donna Hogge, et al.
Pageof 31

Showing results (11-20 of 308) with videos related to

Sort By:
Pageof 31
Leukemia Research|July 16, 2003
Prognostic significance of trisomy 4 as the sole cytogenetic abnormality in acute myeloid leukemiaVikas Gupta, Mark D Minden, Qi-Long Yi, et al.
Nutrition and Cancer|January 31, 2025
Dietary Modulation of Fatty Acid Oxidation Imparts Stem Cell Protection in Bone MarrowNawaz Ahmed, Sarah Walker, Alessia Roma, et al.
Molecular & Cellular Oncology|October 7, 2021
Novel subtypes of <i>NPM1</i>-mutated AML with distinct outcomeArvind Singh Mer, Mark D Minden, Benjamin Haibe-Kains, et al.
International Journal of Molecular Sciences|June 27, 2024
Pseudolaric Acid B Targets CD147 to Selectively Kill Acute Myeloid Leukemia CellsSheng Zou, Ekaterina Parfenova, Nikolina Vrdoljak, et al.
Leukemia|December 14, 2019
NPM1c impedes CTCF functions through cytoplasmic mislocalization in acute myeloid leukemiaAtom J Wang, Youqi Han, Nanyang Jia, et al.
Current Treatment Options in Oncology|April 30, 2003
Bcl-2 and apoptosis in chronic lymphocytic leukemiaAaron D Schimmer, Irene Munk-Pedersen, Mark D Minden, et al.
Breast Cancer Research : BCR|July 20, 2007
The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cellsYouqi Han, Serban San-Marina, Lin Yang, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 26, 2018
Targeting chemotherapy-resistant leukemia by combining DNT cellular therapy with conventional chemotherapyBranson Chen, Jong Bok Lee, Hyeonjeong Kang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 16, 2008
Drug-resistant AML cells and primary AML specimens are killed by 111In-anti-CD33 monoclonal antibodies modified with nuclear localizing peptide sequencesVeerle Kersemans, Bart Cornelissen, Mark D Minden, et al.
Clinical Laboratory International|January 5, 2016
Insights into acute myeloid leukemia via single cell network profilingSteven M Kornblau, Mark D Minden, Donna Hogge, et al.
Pageof 31